CLINICAL_TRIALS
other
· 2007-06-06
Clinical Trial Update: NeuroPath Comparative Validation Study Plan [Phase 3]
Summary
The NeuroPath Phase 3 comparative validation study plan for Carpal Tunnel Syndrome has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Excel-Tech Ltd. | Conditions: Carpal Tunnel Syndrome (CTS) | Phase 3 | Status: TERMINATED